Sustained Complete Response to Palbociclib in a Refractory Pediatric Sarcoma With BCOR-CCNB3 Fusion and Germline CDKN2B Variant

Simple item page
dc.contributor.authorTramontana, Timothy F.
dc.contributor.authorMarshall, Mark S.
dc.contributor.authorHelvie, Amy E.
dc.contributor.authorSchmitt, Morgan R.
dc.contributor.authorIvanovich, Jennifer
dc.contributor.authorCarter, Jacquelyn L.
dc.contributor.authorRenbarger, Jamie L.
dc.contributor.authorFerguson, Michael J.
dc.contributor.departmentPediatrics, School of Medicineen_US
dc.date.accessioned2021-05-28T21:53:45Z
dc.date.available2021-05-28T21:53:45Z
dc.date.issued2020-04-30
dc.identifier.citationTramontana, T. F., Marshall, M. S., Helvie, A. E., Schmitt, M. R., Ivanovich, J., Carter, J. L., Renbarger, J. L., & Ferguson, M. J. (2020). Sustained Complete Response to Palbociclib in a Refractory Pediatric Sarcoma With BCOR-CCNB3 Fusion and Germline CDKN2B Variant. JCO Precision Oncology, 4, 466–471. https://doi.org/10.1200/PO.19.00258en_US
dc.identifier.urihttps://hdl.handle.net/1805/26062
dc.language.isoenen_US
dc.publisherWolters Kluweren_US
dc.relation.isversionof10.1200/PO.19.00258en_US
dc.relation.journalJCO Precision Oncologyen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0*
dc.sourcePMCen_US
dc.subjectEwing sarcomaen_US
dc.subjectBCOR-CCNB3–fused sarcomasen_US
dc.subjectRefractory Pediatric Sarcomaen_US
dc.titleSustained Complete Response to Palbociclib in a Refractory Pediatric Sarcoma With BCOR-CCNB3 Fusion and Germline CDKN2B Varianten_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
PO.19.00258.pdf
Size:
1.05 MB
Format:
Adobe Portable Document Format
Description:
Main article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles
Department of Pediatrics Works